SOLIDARITY: AN INTERNATIONAL RANDOMIZED CONTROLLED TRIAL TO EVALUATE NON-LICENSED COVID-19 TREATMENTS IN ADDITION TO STANDARD OF CARE AMONG HOSPITALIZED PATIENTS
Not Applicable
Recruiting
- Conditions
- -B342 Coronavirus infection, unspecified siteCoronavirus infection, unspecified siteB342
- Registration Number
- PER-010-20
- Lead Sponsor
- OMS/OPS,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 719
Inclusion Criteria
Adults ≥18 years, able to give informed consent, hospitalized or recently admitted as hospitalized patients diagnosed with COVID-19 and without advance transfer within 72 hours to a hospital that is not participating in the study. Patients invited to join the study will be those who report to hospitals / clinics, and there will be no other recruitment efforts
Exclusion Criteria
Research subjects under the age of 18, undiagnosed with COVID-19, with a history of known allergy and contraindications to study treatments (eg, chronic liver disease, chronic heart disease, or are pregnant).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method